Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice. Iraqi J. Vet. Med. 2022;46(2):53-65. doi:10.30539/ijvm.v46i2.1554